Mette Bøgelund Selected Research

Mette Bøgelund Research Topics

4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2011
3	Allergic Rhinitis 02/2022 - 01/2021
3	Hypersensitivity (Allergy) 02/2022 - 01/2021
3	Weight Gain 01/2016 - 09/2011
2	Obesity 01/2022 - 12/2021
2	Weight Loss (Weight Reduction) 12/2021 - 01/2016
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 09/2011
2	Hypoglycemia (Reactive Hypoglycemia) 01/2013 - 09/2011
1	COVID-19 01/2021
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 10/2018
1	Pain (Aches) 10/2018
1	Multiple Sclerosis 08/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2017
1	Body Weight (Weight, Body) 01/2016
1	Schizophrenia (Dementia Praecox) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2016
1	Atrophy 03/2013
1	Nausea 11/2011

3	TabletsIBA 02/2022 - 01/2016
3	Insulin (Novolin)FDA Link 12/2017 - 01/2016
2	Hypoglycemic Agents (Hypoglycemics)IBA 12/2017 - 01/2013
2	Blood Glucose (Blood Sugar)IBA 11/2011 - 09/2011
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Loxapine (Loxitane)FDA LinkGeneric 01/2016
1	Estrogens (Estrogen)FDA Link 03/2013
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 09/2011

6	Therapeutics 12/2021 - 09/2011
6	Injections 01/2021 - 09/2011
3	Immunotherapy 02/2022 - 01/2021
2	Nebulizers and Vaporizers (Inhaler) 01/2017 - 01/2016
1	Bariatric Surgery 01/2022
1	Length of Stay 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Mechanical Ventilators (Ventilator) 01/2021
1	Catheters 10/2018
1	Glycemic Control 12/2017